The Venture Codex Logo

The Venture Codex

Dioko Health Ventures

5314 Maryland Way, Suite 100, Brentwood, Tennessee, 37027, United States

Overview

Dioko Ventures targets early stage investment opportunities with a focus on healthcare services and information technology meeting the following criteria: Healthcare and technology startups led by strong management teams with sector specific expertise,Ventures at an early stage enabling the fund to obtain meaningful ownership and serve on the board of directors to help the company as they scale,Business investment opportunities that are driving change in healthcare and helping current institutions adapt to a world in which they must be better, faster, and cheaper Technologies that are largely outside the scope of healthcare EMR solutions

Total investments
5
Lead investments
3
Investments · 12mo
0
Active investors
0

Sector focus

  • Health Care
  • Impact Investing
Visit website

Investment portfolio

  • SonderMind

    Participated · Series B · Apr 2020

    SonderMind operates a technology platform that connects individuals with therapists who accept their insurance and are a clinical fit, while providing therapists with billing, telehealth, clinical assessments and practice support. The company emphasizes personalized mental health journeys and data-driven, clinically verifiable outcomes for users. SonderMind’s platform handles matching, payments, telehealth and a full technology suite so clinicians can focus on care. The company says the new funding will accelerate expansion into all fifty states and bolster its technology capabilities. SonderMind positions itself around affordability and accessibility, aiming to help millions of Americans find the right therapist. As of the announced round, the company has raised a total of $183 million in capital. SonderMind operates a marketplace that connects consumers to licensed behavioral-health professionals while enabling clinicians to focus on care rather than running a practice. Its SonderMind Solution™ handles matching clients, payments, telehealth, a full technology suite, clinical assessments and a supportive team of behavioral-health experts. The company currently operates the largest integrated network of community behavioral-health professionals in Colorado and is expanding its business in Texas and Arizona. SonderMind intends to use new capital to accelerate entry into new markets, deepen and broaden enterprise partnerships with payors, employers and health systems, and further build out the technology platform that drives its solution. Leadership includes co-founder and CEO Mark Frank, and the company recently added Eric Roza and Kent Thiry to its board. SonderMind completed a $27 million Series B financing to support these growth plans. SonderMind offers the SonderMind Solution™, a behavioral-health platform that matches clients to vetted therapists while handling scheduling, payments, insurance coordination, and a lightweight EHR and practice-management tools. The product includes a matching platform that factors clinical fit and mutual preferences, a mobile app with voice notes, calendar and messaging, and support for provider billing and administration. The company operates the largest integrated network of community behavioral-health professionals in Colorado. SonderMind plans to expand beyond Colorado into Austin, Texas and Phoenix, Arizona in the near term and to scale the offering nationally. Financially, the company completed a $3 million Series A in April 2019 to support ongoing launch, program and technology initiatives and to hire key personnel. The company also appointed Jonathan S. Bush to its board as it executes its growth strategy from its Denver base.

  • Feedtrail

    Led · Seed · May 2019

    Feedtrail offers secure, cloud-based experience management (XM) solutions and advanced data analytics that enable customer experience teams to engage and connect with the right people at the right time. Its platform uncovers prescriptive insights and allows teams to take purposeful action to drive continuous improvement and measurable results across the lifecycle of care. The company serves more than 70 health systems across 4,000 sites in 14 countries and counts Novant Health, Cedars-Sinai, USC Keck and Sentara Healthcare among its customers. Led by CEO Stephanie Alexander and Chief Strategy Officer Paul Jaglowski, Feedtrail focuses on enhancing actionable tools to improve patient and employee experiences while driving strategy, communication, and brand loyalty. The business intends to use recent funding to scale and meet demand for its platform and to advance its technology. Feedtrail is based in Raleigh, N.C. Founded in 2015 and based in North Carolina, Feedtrail specializes in phone-based patient satisfaction surveys that are analyzed to produce feedback and action plans for providers. The platform surfaces department-specific opportunities, tracks patient retention and satisfaction trends, and issues alerts when patients give negative feedback. Feedtrail also provides suggested strategies and methods to help providers address logistical issues and prioritize workflow. The product is designed to help clinical teams recalibrate in real time and improve the patient-provider relationship. The company recently closed a funding round and plans to use proceeds to hire sales and marketing staff and to scale the platform. Market demand is rising as hospitals and providers invest more in the patient experience.

  • RubiconMD

    Participated · Series A · Jun 2016

    RubiconMD operates a digital eConsult platform that connects primary care clinicians with specialist insights to reduce unnecessary referrals and patient wait times. Launched in 2013 by Gil Addo and Carlos Reines, the platform offers quick access across more than 120 specialties and has partnered with major payors. The company aims to enable primary care to practice at the top of its license and to improve quality and affordability amid a shift toward value-based care. RubiconMD plans to leverage its data to deliver new product offerings for primary care clinicians and to expand its reach. Financially, the company has raised more than $40 million to date, including an $18 million Series C announced in this round. The new capital is intended to fuel ongoing growth and product development. RubiconMD provides a digital consult platform that connects primary care doctors with specialists. The company is New York-based and launched in 2013. RubiconMD announced a $13.8 million Series B round. The Series B was led by HLM Venture Partners and Optum Ventures and included Centene Corporation and Blue Ivy Ventures. The round also included all participating investors from its Series A. RubiconMD previously raised a $4 million Series A in mid-2016. RubiconMD operates a platform that allows primary care providers to request same-day eConsults from top medical specialists to improve patient care. Launched in 2013 and based in New York City, the company aims to unlock medical expertise by removing access barriers to specialty care. Its platform is intended to cut health care costs, save time, and streamline care so primary care providers can make faster, more informed recommendations. RubiconMD has an ongoing partnership with Zuckerberg San Francisco General Hospital and Trauma Center and is expanding its presence in California. The company recently added strategic hires — including Christine Peterson as Head of Customer Success in Berkeley — and expanded its advisory board with Hal Yee Jr., M.D., Ph.D. These moves, together with a direct investment from Heritage Provider Network, are intended to build California infrastructure and reach underserved populations on the West Coast. Launched in 2013 and based in New York City, RubiconMD offers eConsult, a digital messaging platform that connects primary care clinicians with specialists across more than 100 specialties and sub‑specialties. Clinicians use the app on any device and are algorithmically matched to a specialist, receiving educational responses usually within four hours or less. The platform is intended to create a collaborative medicine environment to help primary care providers make more informed patient care plans and to democratize medical expertise. The company has pursued opportunities to expand access in underserved regions, with a stated focus on improving specialty care access for Medi‑Cal enrollees in California, including rural areas. RubiconMD has participated in the athenahealth accelerator and is a graduate of Blueprint Health. The company recently announced a $750,000 investment from the California Health Care Foundation Innovation Fund and has raised over $6 million to date. RubiconMD operates an eConsult platform that connects primary care providers to a panel of specialists, allowing clinicians to upload images, labs, and studies and receive expert answers within hours. The system uses smart routing to identify the appropriate specialist and is designed to fit into primary care workflows to reduce unnecessary referrals, shorten patient wait times, and optimize care plans. The company has implemented its product with customers across twenty-six states. RubiconMD validated its model in a study finding that 97% of eConsults offered meaningful support to clinicians and 72% directly improved care plans. Launched in 2013 by two Harvard MBAs and a physician on the faculty at Harvard Medical School, the company recently closed a $4.0 million Series A to expand access and invest in product enhancements and data analytics.

  • Novarus Healthcare

    Led · Equity · Apr 2016

    Novarus Healthcare, founded in 2011 and based in Charlotte, N.C., develops healthcare IT solutions for employers to improve healthcare, employee engagement, and benefits delivery. Its flagship products include Novarus EmployeeConnect, a mobile app that helps employers engage employees, facilitate collaboration, promote company objectives, and provide accessible benefits information, and Novarus BERT, a tool for benefits invoice reconciliation that identifies and resolves errors. The company raised $750K in equity funding to continue enhancing its technologies and expand its reach. Dioko Health Ventures led the investment and its managing partner, Matthew King, joined Novarus’ board of directors as part of the deal. Novarus focuses on improving benefits administration and operational efficiency for employer clients. The company intends to use the funds to further develop its offerings and broaden deployment among employers.

Team

No current team members are available.